Chicago, IL (October 8, 2015) – Just one month until NephCure Kidney International’s (NKI) Chicago fundraising gala. This inaugural event will be held on Friday, November 6, 2015 from 7:30 … Read more
Initiative seeks to create interventions to prevent kidney failure and improve access to kidney disease research, care for communities of color King of Prussia, PA – March … Read more
Our Impact Building a Better World for People with Rare Kidney Disease Until just recently, rare kidney disease was full of “unknowns” — Who’s most at risk? What treatments work … Read more
The Turner family and Jet Food Stores change the face of kidney disease, one kidney at a time. On June 2, Jet Food Stores will launch their seventh annual Kidney … Read more
May 12, 2014 On May 1, 2014 more than 100 advocates met with 133 congressional offices, including with 19 Senators and Representatives to raise the profile of kidney disease and make … Read more
The NephCure Foundation is Now NephCure Kidney International New Name, Same Dedication to a Cure for FSGS and the diseases that cause Nephrotic Syndrome “We are here to create … Read more
The NephCure Kidney Walk returns for the 6th year to the Atlanta area, Saturday, September 26th. The walk brings together Atlanta area patients, friends, and family dedicated to raising awareness … Read more
Goldfinch Bio is a biotechnology company based in Cambridge, MA which focuses on advancing kidney precision medicine. Its mission is to deliver disease-modifying precision medicine that brings hope and renewed … Read more
What is sparsentan and how is it taken? Sparsentan is a novel Dual Endothelin Angiotensin Receptor Antagonist (DEARA) being studied as a potential treatment option for immunoglobulin A (IgA) nephropathy … Read more
May 1, 2014 On May 6, Jet Food Stores will host the NephCure Golf Classic at Twin City Country Club in Sandersville, Georgia. The event will benefit the NephCure International … Read more
NephCure Kidney International (NKI) rang the opening bell at the New York Stock Exchange (NYSE) at 9:30 AM Friday, August 15, 2014. “We are thrilled to have been asked and for the … Read more
NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.
EN 
ES 